Jun Sasaki, President and CEO of Rena Therapeutics Inc. made a presentation at “Nucleic Acids Therapeutics Society of Japan” held in Kyushu. July 9, 2018
Jun Sasaki, President and CEO of Rena Therapeutics Inc. gives a presentation at Network Night” held by INCJ. May 10, 2018
Exhibited the panel at INCJ booth in BioJapan2017 held in PACIFICO Yokohama for introducing our business and technology October 11-13, 2017
Participated in 3rd Annual Meeting of the Nucleic Acids Therapeutics Society of Japan in Hokkaido July 12-14, 2017
Participated in BIO International Convention 2017 in San Diego, California June 19-22, 2017
Our platform Hetero-Duplex Oligonucleotide Technology’s basic patent was registered in Japan(Patent No.JP6112569) March 24, 2017
Made a presentation at “BioAsia2017” held in Roppongi Tokyo, co-hosted by BioCentury and JBA(Japan Bioindustry Association) March 15, 2017
Made a presentation at “Biotechnology-related industry matching meeting & presentation at Nihonbashi” hosted by Kanto Bureau of Economy, Trade and Industry, METI January 26, 2017
Rena Therapeutics Inc. marked the second anniversary January 15, 2017
Junichi Yano was appointed Chairman, and Jun Sasaki was appointed President & CEO December 15, 2016
Exhibited the panel at INCJ booth in BioJapan2016 held in PACIFICO Yokohama for introducing our business and technology October 12-14, 2016
Press conference August 7, 2015
Series A funding from Innovation Network Corporation of Japan, DBJ Capital Co., Ltd. and KSP Inc. is completed April 20, 2015
Granted university ventures honor from Tokyo Medical and Dental University February 25, 2015
